NEW YORK STATE COMMON RETIREMENT FUND - PRELUDE THERAPEUTICS INC ownership

PRELUDE THERAPEUTICS INC's ticker is PRLD and the CUSIP is 74065P101. A total of 61 filers reported holding PRELUDE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 6.00 and the average weighting 0.0%.

Quarter-by-quarter ownership
NEW YORK STATE COMMON RETIREMENT FUND ownership history of PRELUDE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$62
-31.1%
20,149
+0.7%
0.00%
Q2 2023$9020,000
+21639.1%
0.00%
Q2 2022$0
-100.0%
92
-98.2%
0.00%
Q1 2022$34,000
-69.9%
4,992
-45.1%
0.00%
Q4 2021$113,000
-60.4%
9,092
-0.2%
0.00%
Q3 2021$285,000
+9.6%
9,109
+0.4%
0.00%
Q2 2021$260,000
-33.3%
9,075
+0.8%
0.00%
Q1 2021$390,000
-24.3%
9,000
+25.0%
0.00%
-100.0%
Q4 2020$515,0007,2000.00%
Other shareholders
PRELUDE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Orbimed Advisors 10,039,691$69,274,0001.12%
Baker Brothers Advisors 10,123,824$69,854,0000.40%
HHLR ADVISORS, LTD. 583,333$4,025,0000.08%
Rock Springs Capital Management LP 368,959$2,546,0000.06%
PDT Partners, LLC 71,822$496,0000.04%
Virtus ETF Advisers LLC 13,048$90,0000.04%
Corton Capital Inc. 10,918$75,0000.03%
GSA CAPITAL PARTNERS LLP 23,201$160,0000.02%
OCCUDO QUANTITATIVE STRATEGIES LP 24,238$167,0000.01%
IndexIQ Advisors LLC 56,750$392,0000.01%
View complete list of PRELUDE THERAPEUTICS INC shareholders